ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of Anhydrodebromoaplysiatoxin as a Dichotomic Autophagy Inhibitor

Feng, Limin; Lu, Chung-Kuang; Wu, Jiajun; Chan, Leo Lai*; Yue, Jianbo*
Marine Drugs2023-1DOI: 10.3390/md21010046
2被引13阅读
引用收藏
分享

摘要

Dysfunctional autophagy is associated with various human diseases, e.g., cancer. The discovery of small molecules modulating autophagy with therapeutic potential could be significant. To this end, we screened the ability of a series of metabolites isolated from marine microorganisms to modulate autophagy. Anhydrodebromoaplysiatoxin (ADAT), a metabolite yielded by the marine red algae Gracilaria coronopifolia, inhibited autophagosome-lysosome fusion in mammalian cells, thereby inducing the accumulation of autophagosomes. Treatment of cells with ADAT alkalinized lysosomal pH. Interestingly, ADAT also activated the mTOR/p70S6K/FoxO3a signaling pathway, likely leading to the inhibition of autophagy induction. ADAT had little effect on apoptosis. Our results suggest that ADAT is a dichotomic autophagy inhibitor that inhibits both late-stage (autophagosome-lysosome fusion) and early-stage (autophagy induction) autophagy.

学科与关键词

关键词
anhydrodebromoaplysiatoxinautophagymTORFoxO3alysosome
相关
加载中…
  • Cyclovirobuxine D Induces Autophagy-Associated Cell Death via the Akt/mTOR Pathway in MCF-7 Human Breast Cancer Cells
    Lu Jing; Sun Duanping; Gao Si; Gao Ying; Ye Jiantao*; Liu PeiqingJOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 125(1): 74-82.被引 8
  • Inhibition of autophagy potentiates the apoptosis-inducing effects of photodynamic therapy on human colon cancer cells
    Guoqing, Ouyang; Li, Xiong; Zhipeng, Liu; Brandon, Lam; Brian, Bui; Lun, Ma; Xiang, Chen; Pan, Zhou; Kunpeng, Wang; Zijian, Zhang; He, Huang; Xiongying, Miao; Wei, Chen; Yu, WenPhotodiagnosis and Photodynamic Therapy, 2018, 21: 396-403.被引 11
  • The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells-Implications for Autophagy Modulation as a Therapeutic Strategy
    Xu, Jingwen; Elshazly, Ahmed M.; Gewirtz, David A.*Biomedicines, 2022, 10(7): 1632.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Marine Drugs
发表日期
2023-01
卷期
第 21 卷, 第 1 期
页码
46
DOI
10.3390/md21010046
语言
ENGLISH
成果收录
SCIE
资助标注
Shenzhen Government Research Grant [JCYJ20180307123912136, SGDX20201103093201010, JSGG20200225150702770, JCYJ20210324134007020]; National Natural Science Foundation of China (NSFC) [81903535, 21778045, 32070702, 82161128014]; ITF [GHP/097/20GD, MHP/072/21, 2018M633163]; China Postdoctoral Science Foundation; [MRP/064/21]

作者

  • F

    Feng, Limin (第一作者)

  • L

    Lu, Chung-Kuang

查看全部 5 位作者收起作者
  • W

    Wu, Jiajun

  • C

    Chan, Leo Lai (通讯)

  • Y

    Yue, Jianbo (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417